Article info

Download PDFPDF
Original research
Treatment switch in Fabry disease- a matter of dose?

Authors

  • Malte Lenders Internal Medicine D, Department of Nephrology, Hypertension and Rheumatology and Interdisciplinary Fabry Center Münster (IFAZ), University Hospital Münster, Münster, Germany PubMed articlesGoogle scholar articles
  • Peter Nordbeck Department of Internal Medicine I, Divisions of Cardiology and Nephrology, Comprehensive Heart Failure Center, Fabry Center for Interdisciplinary Therapy (FAZIT), University Hospital and University of Würzburg, Würzburg, Germany PubMed articlesGoogle scholar articles
  • Sima Canaan-Kühl Department of Medicine, Division of Nephrology, Charité, Universitätsmedizin Campus Mitte, Berlin, Germany PubMed articlesGoogle scholar articles
  • Lukas Kreul Department of Internal Medicine I, Divisions of Cardiology and Nephrology, Comprehensive Heart Failure Center, Fabry Center for Interdisciplinary Therapy (FAZIT), University Hospital and University of Würzburg, Würzburg, Germany PubMed articlesGoogle scholar articles
  • Thomas Duning Department of Neurology, and Interdisciplinary Fabry Center Münster (IFAZ), University Hospital Münster, Münster, Germany PubMed articlesGoogle scholar articles
  • Lora Lorenz Department of Internal Medicine I, Divisions of Cardiology and Nephrology, Comprehensive Heart Failure Center, Fabry Center for Interdisciplinary Therapy (FAZIT), University Hospital and University of Würzburg, Würzburg, Germany PubMed articlesGoogle scholar articles
  • Christian Pogoda Department of Cardiology I – Coronary and Peripheral Vascular Disease, Heart Failure, and Interdisciplinary Fabry Center Münster (IFAZ), University Hospital Münster, Münster, Germany PubMed articlesGoogle scholar articles
  • Stefan-Martin Brand Institute of Sports Medicine, Molecular Genetics of Cardiovascular Disease, and Interdisciplinary Fabry Center Münster (IFAZ), University Hospital Münster, Münster, Germany PubMed articlesGoogle scholar articles
  • Christoph Wanner Department of Internal Medicine I, Divisions of Cardiology and Nephrology, Comprehensive Heart Failure Center, Fabry Center for Interdisciplinary Therapy (FAZIT), University Hospital and University of Würzburg, Würzburg, Germany PubMed articlesGoogle scholar articles
  • Eva Brand Internal Medicine D, Department of Nephrology, Hypertension and Rheumatology and Interdisciplinary Fabry Center Münster (IFAZ), University Hospital Münster, Münster, Germany PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Eva Brand, Internal Medicine D, Department of Nephrology, Hypertension and Rheumatology and Interdisciplinary Fabry Center Münster (IFAZ), University Hospital Münster, Münster, Germany; Eva.Brand{at}ukmuenster.de
View Full Text

Citation

Lenders M, Nordbeck P, Canaan-Kühl S, et al
Treatment switch in Fabry disease- a matter of dose?

Publication history

  • Received January 20, 2020
  • Revised May 4, 2020
  • Accepted May 5, 2020
  • First published June 10, 2020.
Online issue publication 
April 27, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.